El aumento de declarar cánceres de origen laboral es tarea de todos. Sí eres médico, y sospechas de un tumor de origen laboral, indícalo en la historia clínica. Puedes ayudar a muchos

Our paper “Discovery of recessive effect of human polymerase δ proofreading deficiency through mutational analysis of POLD1-mutated normal and cancer cells”
European Journal of Human Genetics

rdcu.be/dFCL2

Hard collaborative work, complex analyses, and nerdy thoughts were put into it.

Our work on spatial transcriptomic analysis and biomarkers of chemoimmunotherapy outcome in human ES-SCLC is out in Clinical Cancer Research! Thanks to all people involved in this translational study! Luis Paz-Ares
aacrjournals.org/clincancerres/…

⭕Para M.Provencio, presidente del GECP👨‍⚕️ 'Se necesita mayor respaldo público e inversión para que la investigación siga siendo independiente 👉El papel de los grupos cooperativos de investigación es fundamental ' buff.ly/49H5BlO

Checkout our new Molecular OncologyLab website!
anagnostoulab.org
We are looking for new wet lab members to join our multi-omics and liquid biopsy efforts (research tech and post-doc level -the latter for folks with a PhD in cancer biology-), contact us if there is interest!

Thrilled to present our poster at #AACR24 exploring the role of gut microbiota in shaping chemo-immunotherapy outcomes for locally advanced NSCLC 🦠🦠 LiquidBiopsyLabPdH

🙇‍♀️Apunta esta fecha en tu agenda: el próximo 21 y 22 de noviembre el GECP celebra el Madrid el XIII Simposio Educacional donde hablaremos de forma transversal sobre diferentes temas referidos al cáncer de pulmón. 🤔 ¿Te lo vas a perder?

Excellent presentation by Ernest Nadal at #AACR24 , exploring the combination of immunotherapy and PARP inhibitors (iPARP).

One of the great perks of #AACR24 is the opportunity to reconnect with colleagues and collaborators from around the world! LiquidBiopsyLabPdH Grupo Español de Cáncer de Pulmón AACR Johns Hopkins Thoracic Oncology

European Lung Cancer Congress, Prague

⭐️ Learning from the pioneers of #NADIM trial and the predictive role of microbiota in this trial. #ELCC24 #LCSM #ESMOAmbassadors ESMO - Eur. Oncology Grupo Español de Cáncer de Pulmón

Our findings in CLARIFY project and iberoamerican LUDICAS study continue to support that sexual dysfunction related to oncologic treatment is an important problem in patients with LC. Poster session 251P/252P #ELCC2024 ESMO - Eur. Oncology Grupo Español de Cáncer de Pulmón Clarify Project

🦠 The #ELCC24 educational session on modulating the IO response with bacteria, moderated by lisaderosa of Gustave Roussy and Dr. Paul Baas of The Netherlands Cancer Institute and Antoni van Leeuwenhoek, is underway until noon CET.

Generando información para el urgente cambio en las leyes antitabaco
Pedro Gullón Tosio USC Grupo Español de Cáncer de Pulmón

At #ELCC2024 presenting our results on gut microbiome analysis Grupo Español de Cáncer de Pulmón

#ELCC24 : Read the interview by Enriqueta Felip where she discussed how the transformative effect of #PrecisionOncology is evolving from adv to early-stage #NSCLC w/ new opportunities for collaboration & multidisciplinary management.
#ESMODailyReporter
👉 ow.ly/lgUR50QXzfy

How can #liquidbiopsies uniquely interpret the efficacy of novel #immunotherapy combinations in the neoadjuvant space?
Just out #openaccess in Nature Medicine
nature.com/articles/s4159…
short📽️youtu.be/6qwHLH8uTAQ

EC Action Network Johns Hopkins Thoracic Oncology Cancer Research Institute Vincent Lam

Opening #ELCC24 with chairs Drs. Natasha Leighl and Paul Baas honoring the great Dr. Enriqueta Felip with the 2024 Heine H. Hansen Award! Such an impactful clinician, researcher, and colleague - incredibly deserving. Congratulations!
ESMO - Eur. Oncology IASLC #ESMOAmbassadors

Thanks to Worldwide Cancer Research and their supporters for funding our project CNIO Stop Cancer. We will try to understand the impact of obesity in breast cancer cell dissemination and metastasis. So exited to start this project !! 🧑‍🔬
worldwidecancerresearch.org/what-we-do/our…

Here's our latest from Johns Hopkins Thoracic Oncology & Molecular OncologyLab, hot-off-the-press in Nature Medicine. What do we learn from neoadjuvant anti-PD1 & anti-LAG3 through the lens of liquid biopsies? Enjoy the read!
nature.com/articles/s4159…
Vincent Lam Cancer Research Institute Blair Landon